US Pharma MarketingWhy Omada is staying in its lane
Omada Health Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and drug approvals: What’s…
It’s been a little more than a year since Omada Health went public, and the company reported its first profitable quarter this spring. Now, it's preparing for its first CEO transition.
Wei-Li Shao, who joined ...
Source: Endpoints News